NCT00027287
- Conditions
- Autoimmune Diseases, Cardiovascular Diseases, Diabetes Complications, +16 more
- Locations
-
- National Eye Institute (NEI) Bethesda, Maryland, United States
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
7,968 public trials
717 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00005760
- Conditions
- Body Weight, Cardiovascular Diseases, Diabetes Mellitus, +22 more
- Locations
-
- National Institute of Child Health and Human Development (NICHD) Bethesda, Maryland, United States
NCT00001870
- Conditions
- Ascorbic Acid Deficiency, Avitaminosis, Deficiency Diseases, +12 more
- Locations
-
- National Center for Complementary and Alternative Medicine (NCCAM) Bethesda, Maryland, United States
NCT00622960
- Conditions
- Body Weight, Body Weight Changes, Diabetes Mellitus, +13 more
- Locations
-
- University of Cincinnati Cincinnati, Ohio, United States
Completed
A Phase 1/2a Study of the 2S,4R Enantiomer of Ketoconazole in Subjects With Type 2 Diabetes Mellitus
NCT00302224
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Asha Thomas, MD - Medstar Washington D.C., District of Columbia, United States
- Marc Rendell, MD - Creighton University Omaha, Nebraska, United States
- Dr. Andrew Ahmann, MD - Radiant Research Portland, Oregon, United States
- Carlos Arauz-Pacheco, MD - Radiant Research Dallas, Texas, United States
NCT00398060
- Conditions
- Behavior, Body Weight, Diabetes Mellitus, +14 more
- Locations
-
- Päijät-Häme Hospital District Lahti, Finland
NCT00612625
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark
NCT00143338
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site San Antonio, Texas, United States
NCT00612950
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Dept. of Endocrinology, Hvidovre Hospital Copenhagen, Denmark
Completed
US Inhaled Insulin Dose Titration Study
NCT00246623
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site New Britain, Connecticut, United States
- Pfizer Investigational Site Norwalk, Connecticut, United States